Eocene Ltd. (NasdaqCM: EOCN)
Health Care · Biotechnology · IL
$2.48
+3.77% today · -70.5% 1Y
Eocene Ltd. (NasdaqCM: EOCN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.58M and employs 6 people.
Over the last twelve months the share price has lost 70.5%, trading between 2.33 and 12.32.
Tweenvest scores Eocene Ltd. across four factors: quality 37/100, value 56/100. Its strongest factor is value.
EOCN price history
Key figures
- Market cap
- $2.58M
- Revenue (TTM)
- —
- P/E
- -0.23
- EPS
- -14.54
- Dividend yield
- —
- Beta (5Y)
- 0.72
- 52-week high
- $12.32
- 52-week low
- $2.33
- Avg volume (3M)
- —
- Shares outstanding
- 1.04M
- Employees
- 6
- Next earnings
- —
About Eocene Ltd.
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
- ISIN
- IL0011313900
- Founded
- 2000
- Listed since
- Mar 12, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ernexa Therapeutics Inc.NasdaqCM: ERNA | $2.86M | $1.69 | +0.60% |
| Restart Life Sciences Corp.CNSX: HEAL | $2.85M | CA$0.07 | -18.75% |
| Vaccinex, Inc.OTCPK: VCNX | $2.68M | $1.00 | 0.00% |
| Spermosens AB (publ)NGM: SPERM | $2.67M | Skr0.01 | +2.44% |
| Modus Therapeutics Holding AB (publ)OM: MODTX | $2.55M | Skr0.17 | +2.99% |
| Curis, Inc.NasdaqCM: CRIS | $2.52M | $0.61 | +13.38% |
| Dermata Therapeutics, Inc.NasdaqCM: DRMA | $2.50M | $0.62 | -6.01% |
| Quantum Genesis AI Corp.OTCPK: QGAI | $2.46M | $0.06 | +114.29% |